Viewing StudyNCT00171808



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171808
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2005-09-13

Brief Title: Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Endometrial Cancer
Keywords:
Name View
hormone receptor positive View
Endometrial Cancer View
Aromatase inhibitor View
Advanced or recurrent View